Skip to content
value.today

Lifecare ASA

LIFE.OL
$59 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
For year ending December-2025
Net income
$-12 M
-115000.0% margin
Official annual report (ESEF)
Employees
—

Lifecare ASA in brief

Lifecare ASA is a listed company in the Medical Equipment industry, based in Norway. Its last known market value was $59 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $0 M and a net loss of $12 M. Its shares trade under the symbol LIFE.OL (Oslo).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Lifecare ASA timeline

3 events, 2006–2024
  1. 2006
  2. 🏁
    · approximate
    Incorporated as Lifecare ASA
  3. 2018
  4. •
    Legal Entity Identifier issued
    LEI 254900D88MYGZ7JD5P39 registered.
  5. 2024
  6. ✎
    Renamed Lifecare ASA
    Legal name change recorded in the LEI register.

Events of Lifecare ASA from the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$16 M$32 M$48 M$64 M20202021202220232024

World rank over time

▼ down 655 places since 2020
2020-01-01: #23417#23,41720202022-01-07: #32313#32,31320222022-12-25: #28703#28,70320222023-07-30: #28854#28,85420232024-01-05: #24072#24,0722024

Rank in Norway: #141 (Jan 2020) · #266 (Jan 2022) · #199 (Dec 2022) · #198 (Jul 2023) · #170 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
-115000.0%
Operating margin
-125100.0%
Return on equity
—
Liabilities / assets
129.5%
Revenue growth
-95.7%

Financial history

USD · fiscal years · source: official annual reports (ESEF)
RevenueNet income
Fiscal year ending Dec 2024: revenue $0M, net income $-7M$0MFY24Fiscal year ending Dec 2025: revenue $0M, net income $-12M$0MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$0M-95.7%$-13M$-12M-115000.0%
Dec 2024$0M—$-8M$-7M-2904.3%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-11M$1M$-11M$-0.65—
Dec 2024$-6M$1M$-7M$-0.53—

Annual results

Revenue
$0 M
Operating income
$-13 M
Net income
$-12 M

For year ending December-2025 · source: official annual report (ESEF)

Balance sheet

Total assets
$9 M
Total liabilities
$12 M
Total equity
$-3 M

As of December-2025

Lifecare ASA scorecard#

Passes 0 of the 2 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth0 of 1
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-0.65 vs -0.53Diluted EPS -0.65 in fiscal 2025 against -0.53 the year before (report's currency).
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 1
    • ✗Profitable in the newest year-$12 MNet income -$12 M in fiscal 2025.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • –Operating margin above its peers' medianNo operating margin on file.
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial healthnot known
    • –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (esef), the medians of Medical Equipment, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Lifecare ASA: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in NOK millions; per-share figures in NOK; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Lifecare ASA: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023
Income statement
Revenue0.12.54.3
Total costs and expenses1379448
Operating income−130−85−35
Interest and finance income14121.0
Interest expense and finance costs5.00.91.0
Income before tax−121−73−35
Income tax−0.6−0.7−0.1
Net income including minority interests−120−73−35
Minority interests' share of net income−0.7−1.00.1
Net income attributable to shareholders−120−72−35
Earnings per share, basic-6.80-5.73-3.81
Earnings per share, diluted-6.80-5.73-3.81
Balance sheet
Cash and cash equivalents5.762—
Receivables0.12.24.0
Other current assets161112
Current assets227564
Property, plant and equipment18143.2
Right-of-use (leased) assets44116.6
Goodwill7.27.27.2
Non-current assets733822
Total assets9511386
Debt due within a year520—
Current liabilities842911
Lease liabilities (non-current)398.34.7
Non-current liabilities399.29.3
Total liabilities1233920
Total equity−287466
Total liabilities and equity9511386
Cash-flow statement
Depreciation and amortization8.04.93.3
Cash from operating activities−110−66−37
Capital expenditure−6.5−13−1.2
Acquisitions, net of cash acquired——0
Cash from investing activities−6.5−12−1.2
Debt issued490—
Shares issued1710743
Shares bought back—−0.1—
Cash from financing activities619139
Change in cash−56130.7
ReportESEFESEFESEF

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

How Lifecare ASA compares in Medical Equipment

  • Revenue$0 M · higher than 0% of 19
  • Revenue growth-95.7% · higher than 0% of 13

Peer comparison · Medical Equipment

CompanyMarket capP/ENet marginRev. growth
Lifecare ASA🇳🇴$59 M——-95.7%
Avita Medical, Inc.🇺🇸$525 M—-42.6%+11.5%
Viemed Healthcare, Inc.🇺🇸$367 M23.5×5.0%+20.5%
Electromed, Inc.🇺🇸$341 M28.6×15.8%+15.3%
Profound Medical Corp.🇨🇦$240 M—-137.4%+50.8%
Streamex Corp.🇺🇸$52 M——+100.0%
TELA Bio, Inc.🇺🇸$52 M—-53.6%+15.8%
IRIDEX Corporation🇺🇸$12 M—-6.9%+8.2%
Beyond Air, Inc.🇺🇸$4 M—-407.6%+107.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 4, 2026

Figures from Official annual report (ESEF), value.today research, GLEIF register.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Lifecare ASA? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Lifecare ASA's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Lifecare ASA? Suggest a correction